Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
243
-
Total 13F shares, excl. options
-
10M
-
Shares change
-
+379K
-
Total reported value, excl. options
-
$966M
-
Value change
-
+$64.9M
-
Put/Call ratio
-
1.35
-
Number of buys
-
159
-
Number of sells
-
-87
-
Price
-
$96.62
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q1 2021
290 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2021.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 243 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10M shares
of 30.2M outstanding shares and own 33.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.59M shares), VANGUARD GROUP INC (1.05M shares), Invesco Ltd. (563K shares), MORGAN STANLEY (558K shares), STATE STREET CORP (459K shares), BAKER BROS. ADVISORS LP (401K shares), GEODE CAPITAL MANAGEMENT, LLC (268K shares), Nepsis, Inc. (191K shares), NORTHERN TRUST CORP (186K shares), and Bank of New York Mellon Corp (169K shares).
This table shows the top 243 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.